[HTML][HTML] Crossing the blood-brain barrier: advances in nanoparticle technology for drug delivery in neuro-oncology

AM Hersh, S Alomari, BM Tyler - International journal of molecular …, 2022 - mdpi.com
The blood-brain barrier (BBB) constitutes a microvascular network responsible for excluding
most drugs from the brain. Treatment of brain tumors is limited by the impermeability of the …

[HTML][HTML] Modulation of immune responses by particle size and shape

MV Baranov, M Kumar, S Sacanna… - Frontiers in …, 2021 - frontiersin.org
The immune system has to cope with a wide range of irregularly shaped pathogens that can
actively move (eg, by flagella) and also dynamically remodel their shape (eg, transition from …

[HTML][HTML] Advances in nanomaterial-based targeted drug delivery systems

X Cheng, Q Xie, Y Sun - Frontiers in bioengineering and …, 2023 - frontiersin.org
Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …

[HTML][HTML] Simulation of nanoparticles interacting with a cell membrane: probing the structural basis and potential biomedical application

X Zhang, G Ma, W Wei - NPG Asia Materials, 2021 - nature.com
Nanoparticles (NPs), owing to their ultrasmall size, have been extensively researched for
potential applications in biomedicine. During their delivery and functionalization within the …

Influence factors on and potential strategies to amplify receptor-mediated nanodrug delivery across the blood–brain barrier

Y Wei, X Xia, H Li, H Gao - Expert Opinion on Drug Delivery, 2023 - Taylor & Francis
Introduction A major challenge in treating central nervous system (CNS) disorders is to
achieve adequate drug delivery across the blood–brain barrier (BBB). Receptor-mediated …

[HTML][HTML] Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer's disease: Current trends and future perspectives

L La Barbera, E Mauri, M D'Amelio… - Frontiers in neuroscience, 2022 - frontiersin.org
Alzheimer's disease (AD), the most common form of dementia, is a progressive and
multifactorial neurodegenerative disorder whose primary causes are mostly unknown. Due …

[HTML][HTML] Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases

N Singh, S Vishwas, A Kaur, H Kaur, V Kakoty… - Biomedicine & …, 2023 - Elsevier
Sesamol is a lignan of sesame seeds and a natural phenolic molecule that has emerged as
a useful medical agent. Sesamol is a non-toxic phytoconstituent, which exerts certain …

Recent Advances in the Development of Near-Infrared Fluorescent Probes for the in Vivo Brain Imaging of Amyloid-β Species in Alzheimer's Disease

NG Bajad, A Kumar, SK Singh - ACS Chemical Neuroscience, 2023 - ACS Publications
The deposition of β-amyloid (Aβ) plaques in the parenchymal and cortical regions of the
brain of Alzheimer's disease (AD) patients is considered the foremost pathological hallmark …

Advances in designing of polymeric micelles for biomedical application in brain related diseases

J Kaur, M Gulati, B Kapoor, NK Jha, PK Gupta… - Chemico-Biological …, 2022 - Elsevier
In recent years, unique physicochemical properties of amphiphilic block copolymers have
been utilized to design the polymeric micelles for brain-specific delivery of drugs, proteins …

Interaction of 2D nanomaterial with cellular barrier: membrane attachment and intracellular trafficking

L Miao, Y Wei, X Lu, M Jiang, Y Liu, P Li, Y Ren… - Advanced Drug Delivery …, 2023 - Elsevier
The cell membrane serves as a barrier against the free entry of foreign substances into the
cell. Limited by factors such as solubility and targeting, it is difficult for some drugs to pass …